Last update 28 Feb 2026

BEBT-701

Overview

Basic Info

Drug Type
siRNA
Synonyms
BEBT-701
Target
AGT x PCSK9
Action
inhibitors
Mechanism
AGT inhibitors(Angiotensinogen inhibitors), PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic Disease
Active Indication
Hyper LDL cholesterolaemiaHypertensionEssential Hypertension+ [1]
Inactive Indication-
Originator Organization
BeBetter Med, Inc.BeBetter Med, Inc.
Active Organization
BeBetter Med, Inc.BeBetter Med, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

1
Clinical Trials associated with BEBT-701
NCT07368608
/ Not yet recruitingPhase 1/2
A Randomized, Double-blind, Placebo-controlled Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Subcutaneous BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated LDL-C
100 Clinical Results associated with BEBT-701
Login to view more data
100 Translational Medicine associated with BEBT-701
Login to view more data
100 Patents (Medical) associated with BEBT-701
Login to view more data
100 Deals associated with BEBT-701
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 2
China
BeBetter Med, Inc.BeBetter Med, Inc.
26 Jan 2026
Hyper LDL cholesterolaemiaPhase 2
China
BeBetter Med, Inc.BeBetter Med, Inc.
-
HypertensionPhase 2
China
BeBetter Med, Inc.BeBetter Med, Inc.
-
Combined hyperlipidemiaPreclinical
China
BeBetter Med, Inc.BeBetter Med, Inc.
17 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free